Trade Summary

2 months ago, Frost Phillip Md Et Al, serving as Dir, 10% owner at Cocrystal Pharma, Inc. (COCP), purchased 50,000 shares at $0.95 per share, for a total transaction value of $47,280.00. Following this transaction, Frost Phillip Md Et Al now holds 1,915,651 shares of COCP.

This purchase represents a 3.00% increase in Frost Phillip Md Et Al's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, February 6, 2026 and publicly disclosed via SEC Form 4 filing on Monday, February 9, 2026, 3 days after the trade was made.

Cocrystal Pharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.